Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The efficacy of diabetes treatment should not be evaluated solely by HbA1c levels as they should also focus on patient-reported outcomes (PROs), such as patient satisfaction, wellbeing and quality of life. The Diabetes Treatment Satisfaction Questionnaire (DTSQ) has been developed to assess patient satisfaction with diabetes treatment. DTSQ has been translated into more than 100 languages and is widely used in many countries, since it is relatively easy to answer and is used for both patients with and without medical therapy. Novel therapeutic options, such as insulin analogs, incretin-based therapy and sodium-glucose cotransporter 2 (SGLT2) inhibitors, have been shown to improve patient satisfaction using DTSQ for assessments. DTSQ is not only used for comparisons between different medications or treatment strategies, but also can be used to assess the quality of diabetes care in clinical settings. This is important as an improvement in treatment satisfaction may enhance patients’ self-efficacy and adherence to therapy, leading to the achievement of long-term stable glycemic control and reduced risk of diabetic complications. In this review, we summarize the current topics in DTSQ, introducing our own experience, and discuss the role of PROs in diabetes treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 2×
“The UK Prospective Diabetes Study (UKPDS) [1], Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) [2] and Kumamoto Study [3] have established the importance of glycemic control to prevent diabetic complications and based on this evidence, a glycated hemoglobin…”
BackgroundIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Global guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064
Hutchins, V., Zhang, B., Fleurence, R. L., Krishnarajah, G., & Graham, J. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.570745 · Cited by 164 · cited 1×
“The improvement in patient satisfaction has been also shown in the patients treated with incretin-related agents [8,15,16], sodium-glucose cotransporter 2 (SGLT2) inhibitors [17], fixed-dose combination tablets [18] and weekly dipeptidyl peptidase-4 (DPP-4) inhibitors [19].”
BackgroundRodbard, H. W., Peters, A. L., Slee, A., Cao, A., Traina, S. B., & Alba, M. (2017) · Diabetes Care · doi:10.2337/dc16-1353 · Cited by 94 · cited 1×
“The improvement in patient satisfaction has been also shown in the patients treated with incretin-related agents [8,15,16], sodium-glucose cotransporter 2 (SGLT2) inhibitors [17], fixed-dose combination tablets [18] and weekly dipeptidyl peptidase-4 (DPP-4) inhibitors [19].”
Background
Cited by
Wada, E., Onoue, T., Kobayashi, T., Handa, T., Hayase, A., Ito, M., Furukawa, M., Okuji, T., Okada, N., Iwama, S., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001115 · Cited by 157
“28 All these could have contributed to the result of this study.”
Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis
De Groot, J., Wu, D., Flynn, D., Robertson, D., Grant, G., & Sun, J. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i2.170 · Cited by 77
Ko, J., Moon, S., Ajjan, R. A., Lee, M. Y., Lee, H., Choi, B., Park, J., Lee, S., Kang, J., & Park, C. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16304 · Cited by 7
“12,37 To evaluate the benefits of the intervention, we compared the current key outcomes with each participant's health check-up data from the previous 2 years, performed in 2021, serving as a historical control.”
Wajid, M., Sattar, S., Khalid, F., & Masood, M. Q. (2023) · Clinical Medicine Insights: Endocrinology and Diabetes · doi:10.1177/11795514231213568 · Cited by 7
Hayase, A., Onoue, T., Kobayashi, T., Wada, E., Handa, T., Kinoshita, T., Yamagami, A., Yasuda, Y., Iwama, S., Kawaguchi, Y., et al. (2023) · Primary Care Diabetes · doi:10.1016/j.pcd.2023.09.009 · Cited by 5
Metadata
- Authors
- Saisho, Y.
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2018-05-09
- Volume
- 15
- Issue
- 5
- Pages
- 947
- ISSN
- 1660-4601 (ISSN-L)
- OpenAlex
- W2801605705
- Cited by
- 149
- References
- 5
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes. https://app.cochat.ai/papers/10.3390/ijerph15050947
- The paper
- Saisho, Y. (2018). Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph15050947
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.